期刊文献+

老年患者血压水平与颈动脉粥样硬化的相关性研究

Levels of Blood Pressure in Elderly Patients with Hypertension:Associated with Carotid Atherosclerosis
下载PDF
导出
摘要 目的探讨老年高血压患者血压水平与颈动脉粥样硬化的关系。方法将患有原发性高血压120例年龄>60岁的患者,将患者根据收缩压分组:血压严格控制组(血压<130mmHg),血压一般控制组(血压130~139mmHg)。对每位患者进行颈动脉超声检查,记录颈动脉内中膜层的厚度。结果多因素线性回归分析显示,收缩压、总胆固醇、空腹血糖与颈动脉颈动脉内中膜厚度呈正相关,而高密度脂蛋白胆固醇与颈动脉颈动脉内中膜厚度呈负相关。分析显示,收缩压≥140mmHg、总胆固醇为颈动脉粥样斑块形成的危险因素,而高密度脂蛋白胆固醇为其保护性因素。结论血压水平和颈动脉粥样硬化具有显著的相关性,血压水平是老年患者颈动脉粥样硬化及斑块形成的危险因素之一。 Objective To explore the association between blood pressure and carotid atherosclerosis in elderly patients with primary hypertension. Methods A total of 120 patients aged 60 years or over with primary hypertension were recruited and categorized by their systolic blood pressure (SBP): tight control, 〈130 rnm Hg, usual control, 130 - 139 mm Hg; Carotid ultrasonography was performed in all subjects for the evaluation of intima-media thickness (1MT) and plaque. Results Multiple linear regression analysis revealed that systolic blood pressure, total cholesterol, fasting blood glucose and carotid carotid intima thickness was positively correlated, and high-density lipoprotein cholesterol with carotid carotid intima thickness was negatively correlated. The analysis showed that the systolic blood pressure ≥ 140 mm Hg, total cholesterol were the risk factors for carotid plaque formation, and high-density lipoprotein cholesterol was the protective factor. Conclusions There is a significant correlation between the levels of blood pressure and carotid atherosclerosis. Blood pressure level is one of the risk factors of carotid atherosclerosis and plaque formation in elderly patients.
出处 《临床医学工程》 2012年第12期2180-2181,共2页 Clinical Medicine & Engineering
关键词 高血压 颈动脉疾病 危险因子 Hypertension Carotid artery disease Risk factor
  • 相关文献

参考文献5

二级参考文献12

  • 1刘新军,徐延敏.代谢综合征与心血管疾病相关的危险因素及防治策略[J].实用心脑肺血管病杂志,2004,12(6):365-368. 被引量:4
  • 2沈潞华.血脂异常与冠心病的防治[J].实用心脑肺血管病杂志,2006,14(3):178-179. 被引量:3
  • 3Leiter LA,Rosenson RS,Stein E,et al.Efficacy and safety of ro-suvastatin40mg versus atorvastatin80mg in high-risk patientswith hypercholesterolemia:results of the POLARIS study[].Atherosclerosis.2007
  • 4West of Scotland Coronary Prevention Study Group.Influence of pravastatin and plasma lipids on clinical events in the west of Scotland coronary prevention study ( WOSCOPS)[].Circulation.1998
  • 5ShepherdJ,CobbeSM,FordI,etal.Preventionofcoronaryheartdiseasewith pravastatininmenwithhypercholesterolemia[].WestofScotlandCoronaryPreventionStudyGroupNEnglJMed.1995
  • 6Downs JR. Clearfield M,Weis S. et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS.Air Force/Texas Coronary Atherosclerosis Prevention Study[].The Journal of The American Medical Association.1998
  • 7Sever,PS,Dahlof,B,Poulter,NR.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomise[].The Lancet.2003
  • 8No authors listed.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease; the Scandinavian Simvastatin Survival Study 4S[].The Lancet.1994
  • 9Goldberg RB,Mellies MJ,Sacks FM,et al.For the CARE investigators.Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels:sub group analyses in the Cholesterol and Recurrent Events (CARE)trial[].Circulation.1998
  • 10The Long term Intervention with Pravastatin in Ischemic Di sease(LIPID)Study Group.Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease andabroad range of initial cholesterol levels[].The New England Journal of Medicine.1998

共引文献4684

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部